Status:
COMPLETED
Cognitive Function and Glymphatic System in Children with Epilepsy
Lead Sponsor:
Ege University
Conditions:
Epilepsy
Cognitive Dysfunction
Eligibility:
All Genders
8-17 years
Phase:
NA
Brief Summary
Epilepsy, one of the most common neurological disorders in childhood, is a chronic brain disease characterized by neurobiological, psychological and cognitive effects. Neuropeptide-Y (NPY) and neural ...
Eligibility Criteria
Inclusion
- Diagnosed with absence and rolandic type epilepsy according to the International League Against Epilepsy (ILAE) classification.
- No previous respiratory physiotherapy.
- Maximal Inspiratory Pressure (MIP) value is below the expected value according to age and gender.
- Co-operative.
Exclusion
- Diagnosed with respiratory system disease.
- Has kyphoscoliosis and/or advanced postural alignment problems that affect respiratory function.
- Have severe mental problems.
- Receiving ketogenic diet application.
- Have any neuromuscular disease.
- Have severe cardiac involvement, pulmonary embolism, mesenteric or portal thrombosis.
- Diagnosis of inflammatory disease or C-reactive protein (CRP) analysis above normal limits.
- The presence of orthopedic surgery.
Key Trial Info
Start Date :
March 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 29 2024
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06143241
Start Date
March 1 2024
End Date
September 29 2024
Last Update
October 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ege University
Izmir, Bornova, Turkey (Türkiye), 35080